The latest update is out from Clorox ( (CLX) ).
Clorox reported a remarkable 27% net sales increase to $1.76 billion for Q1 fiscal year 2025, rebounding from a previous cyberattack and divesting its Argentina and Better Health VMS businesses. The company’s gross margin grew by 740 basis points, and diluted EPS surged by 371% to $0.80. Clorox’s strategic focus on innovation and brand investment has driven strong growth across segments, allowing it to maintain a positive outlook for fiscal year 2025, with expectations for continued margin improvements and EPS growth.
For an in-depth examination of CLX stock, go to TipRanks’ Stock Analysis page.
